Institutional Ownership Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT). We have compiled data on the 256 institutions that hold shares in the stock, with a total of 107 Million shares, which have been reported (via 13F filing form) to have a value of $344 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jump Financial, LLC
Chicago, IL |
May 14, 2025 Q1 2025 |
253,723
shares
|
$811,913
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Hennion & Walsh Asset Management, Inc.
|
Apr 10, 2025 Q1 2025 |
249,526
shares
|
$798,483
0.09% of portfolio
|
Q1 2025
Added 5.06%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
241,800
shares
|
$773,760
0.3% of portfolio
|
Q1 2025
Added 14.38%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
234,178
shares
|
$749,369
0.0% of portfolio
|
Q1 2025
Added 89.75%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
221,911
shares
|
$710,115
0.21% of portfolio
|
Q4 2024
Added 12.59%
|
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
205,378
shares
|
$657,209
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Exodus Point Capital Management, LP
New York, NY |
May 14, 2025 Q1 2025 |
200,684
shares
|
$642,188
0.01% of portfolio
|
Q1 2025
Added 5.69%
|
|
|
Sovran Advisors, LLC
San Diego, CA |
Jul 09, 2025 Q2 2025 |
196,028
shares
|
$627,289
0.06% of portfolio
|
Q2 2025
Reduced 39.33%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
195,793
shares
|
$626,537
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
184,692
shares
|
$591,014
0.0% of portfolio
|
Q1 2025
Added 32.33%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
178,293
shares
|
$570,537
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
May 15, 2025 Q1 2025 |
178,114
shares
|
$569,964
0.0% of portfolio
|
Q1 2025
Added 0.32%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
167,716
shares
|
$536,691
0.0% of portfolio
|
Q2 2024
Added 4.8%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
166,882
shares
|
$534,022
0.0% of portfolio
|
Q1 2025
Reduced 28.67%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
163,622
shares
|
$523,590
0.0% of portfolio
|
Q1 2025
Added 148.42%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
162,710
shares
|
$520,672
0.0% of portfolio
|
Q1 2025
Reduced 8.82%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
156,000
shares
|
$499,200
1.08% of portfolio
|
Q2 2023
Added 147.62%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
May 14, 2025 Q1 2025 |
155,875
shares
|
$498,800
0.0% of portfolio
|
Q1 2025
Reduced 0.25%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
154,687
shares
|
$494,998
0.0% of portfolio
|
Q1 2025
Added 1.44%
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
153,700
shares
|
$491,840
0.0% of portfolio
|
Q4 2024
Added 23.35%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
May 14, 2025 Q1 2025 |
151,200
shares
|
$483,840
0.0% of portfolio
|
Q1 2025
Added 33.22%
|
|
|
New Leaf Venture Partners, L.L.C.
New York, NY |
May 13, 2025 Q1 2025 |
150,706
shares
|
$482,259
2.26% of portfolio
|
Q2 2024
Added 27.46%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
140,726
shares
|
$450,323
0.04% of portfolio
|
Q1 2025
Reduced 62.83%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
128,471
shares
|
$411,107
0.0% of portfolio
|
Q1 2025
Added 158.39%
|
|
|
Legal & General Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
122,627
shares
|
$392,406
0.0% of portfolio
|
Q4 2023
Reduced 45.82%
|